| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 |
| filingDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a367217db8b12225c24eadcb65992329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd34ec7bf3d355a216b9b39a13594de7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f8cf167e81cc1c1eeb78c0c7d70ab7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef3c2f502cdc669b091d8f4eec7eb261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_652bf958e11874592769386f3004c627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f02f6d093cc02edb536090ea442a438b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2626a1b0749eb494c6a79e7f7a92975 |
| publicationDate |
2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008207704-A1 |
| titleOfInvention |
Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists |
| abstract |
A heteroaryl-imidazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB 1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing a heteroaryl-imidazole compound of formula (I), a pharmaceutical composition containing a heteroaryl-imidazole compound of formula (I), and a method for preventing or treating obesity and obesity-related metabolic disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011178134-A1 |
| priorityDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |